| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-07 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.17 | 5e-07 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-05 |
| mRNA | masitinib | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-05 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.13 | 9e-05 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |